Atara Biotherapeutics(ATRA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ATRA Atara Biotherapeutics

盘后交易 11-26 18:46:11 EST

12.26

+0.14

+1.16%

盘后12.59

+0.33+2.69%

17:49 EST

最高12.96	最低11.94	成交量6.53万
今开12.52	昨收12.12	日振幅8.46%
总市值7,061万	流通市值5,774万	总股本575.98万
成交额80.71万	换手率1.39%	流通股本471.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ATRA","market":"US","secType":"STK","nameCN":"Atara Biotherapeutics","latestPrice":12.26,"timestamp":1732654800000,"preClose":12.12,"halted":0,"volume":65284,"hourTrading":{"tag":"盘后","latestPrice":12.5899,"preClose":12.26,"latestTime":"17:49 EST","volume":3,"amount":37.7697,"timestamp":1732661354099},"delay":0,"floatShares":4709972,"shares":5759750,"eps":-22.601171,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.14,"latestTime":"11-26 18:46:11 EST","open":12.52,"high":12.96,"low":11.935,"amount":807068.6842680001,"amplitude":0.084571,"askPrice":13.66,"askSize":100,"bidPrice":12.27,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-22.601171,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732669200000},"adr":0,"listingDate":1413432000000,"adjPreClose":12.12,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":12.58,"preClose":12.12,"latestTime":"09:28 EST","volume":825,"amount":10269.000225,"timestamp":1732631280011},"postHourTrading":{"tag":"盘后","latestPrice":12.5899,"preClose":12.26,"latestTime":"17:49 EST","volume":3,"amount":37.7697,"timestamp":1732661354099},"volumeRatio":0.678278,"impliedVol":0.0156,"impliedVolPercentile":0.007},"requestUrl":"/m/hq/s/ATRA/tweets","defaultTab":"tweets","newsList":[{"id":"2486000374","title":"Atara Biotherapeutics, Inc.盘中异动 早盘快速拉升5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486000374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486000374?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:36","pubTimestamp":1732635398,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日23时36分，Atara Biotherapeutics, Inc.股票出现异动，股价急速拉升5.36%。截至发稿，该股报12.77美元/股，成交量1.492万股，换手率0.26%，振幅4.41%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Poseida Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Protagenic Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、木薯科学、Poseida Therapeutics, Inc.较为活跃，换手率分别为32.48%、20.96%、20.54%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Protagenic Therapeutics, Inc.、Fate Therapeutics, Inc.，振幅分别为85.82%、42.94%、31.61%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112623363898e44b4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112623363898e44b4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2486409035","title":"Atara Biotherapeutics, Inc.盘中异动 大幅上涨5.93%报12.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486409035","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486409035?lang=zh_cn&edition=full","pubTime":"2024-11-25 23:07","pubTimestamp":1732547244,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日23时07分，Atara Biotherapeutics, Inc.股票出现异动，股价快速拉升5.93%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.86%。其相关个股中，Alpha Tau Medical Ltd C/Wts 、Ocean Biomedical Inc C/Wts 14/02/2028 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为96.55%、91.92%、54.83%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、180 Life Sciences Corp C/Wts 07/11/2025、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为55.45%、48.93%、47.19%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125230724abde0c6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125230724abde0c6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2485960442","title":"Atara Biotherapeutics, Inc.盘中异动 临近午盘急速拉升5.56%报11.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485960442","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485960442?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:59","pubTimestamp":1732294779,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日00时59分，Atara Biotherapeutics, Inc.股票出现异动，股价急速上涨5.56%。截至发稿，该股报11.20美元/股，成交量1.9841万股，换手率0.34%，振幅7.16%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Replimune Group, Inc.、Exicure, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1817.02%、143.95%、91.90%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Apollomics Inc C/Wts 01/04/2028 、Exicure, Inc.，振幅分别为70.17%、63.64%、45.86%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112300593998e44342&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112300593998e44342&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2485341521","title":"Atara Biotherapeutics, Inc.盘中异动 早盘股价大跌5.34%报10.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485341521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485341521?lang=zh_cn&edition=full","pubTime":"2024-11-21 23:08","pubTimestamp":1732201738,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日23时08分，Atara Biotherapeutics, Inc.股票出现波动，股价大幅下挫5.34%。截至发稿，该股报10.11美元/股，成交量9485股，换手率0.16%，振幅4.92%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121230858a24b872e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121230858a24b872e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2485286471","title":"Atara Biotherapeutics, Inc.盘中异动 快速下挫5.55%报10.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485286471","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485286471?lang=zh_cn&edition=full","pubTime":"2024-11-21 01:30","pubTimestamp":1732123845,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日01时30分，Atara Biotherapeutics, Inc.股票出现异动，股价急速下挫5.55%。截至发稿，该股报10.38美元/股，成交量5.6032万股，换手率0.97%，振幅6.41%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Forte Biosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Exicure, Inc.涨幅较大，Forte Biosciences, Inc.、Silexion Therapeutics Corp、Exicure, Inc.较为活跃，换手率分别为1595.66%、1233.39%、803.13%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Exicure, Inc.，振幅分别为185.64%、169.09%、136.94%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112101304598e43c92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112101304598e43c92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2484979289","title":"Atara Biotherapeutics, Inc.盘中异动 股价大跌5.12%报10.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484979289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484979289?lang=zh_cn&edition=full","pubTime":"2024-11-20 02:35","pubTimestamp":1732041301,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日02时35分，Atara Biotherapeutics, Inc.股票出现波动，股价快速跳水5.12%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.44%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Syros Pharmaceuticals, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Syros Pharmaceuticals, Inc.、Tff Pharmaceuticals, Inc.、Exicure, Inc.较为活跃，换手率分别为977.94%、835.92%、141.48%，振幅较大的相关个股有Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为91.10%、81.67%、62.82%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120023501971a77fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120023501971a77fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2484771766","title":"Atara Biotherapeutics, Inc.2024财年第三财季实现净利润-21.91百万美元，同比增加68.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484771766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484771766?lang=zh_cn&edition=full","pubTime":"2024-11-19 00:00","pubTimestamp":1731945631,"startTime":"0","endTime":"0","summary":"11月19日，Atara Biotherapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-21.91百万美元，同比增加68.61%；其中营业收入为40.19百万美元，同比增加1778.04%，每股基本收益为-2.93美元。从资产负债表来看，Atara Biotherapeutics, Inc.总负债2.33亿美元，其中短期债务15.25百万美元，资产负债比为0.62，流动比率为58.89。机构评级：截至2024年11月19日，当前有4家机构对Atara Biotherapeutics, Inc.目标价做出预测，其中目标均价为14.75美元，其中最低目标价为10.00美元，最高目标价为21.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119000049abccd40a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119000049abccd40a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA"],"gpt_icon":0},{"id":"2484679026","title":"Atara Biotherapeutics, Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484679026","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484679026?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:49","pubTimestamp":1731941343,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时49分，Atara Biotherapeutics, Inc.股票出现异动，股价急速下挫5.00%。截至发稿，该股报11.40美元/股，成交量1.2131万股，换手率0.21%，振幅5.79%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Hcw Biologics Inc.、冠科美博、Fate Therapeutics, Inc.涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为546.30%、375.75%、282.15%，振幅较大的相关个股有Hcw Biologics Inc.、Fate Therapeutics, Inc.、冠科美博，振幅分别为118.81%、62.38%、54.54%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118224903a2433427&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118224903a2433427&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2483372230","title":"Atara Biotherapeutics, Inc.盘中异动 早盘快速下跌5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483372230","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483372230?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:43","pubTimestamp":1731681829,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时43分，Atara Biotherapeutics, Inc.股票出现波动，股价快速跳水5.40%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.84%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Cero Therapeutics Holdings, Inc.涨幅较大，Tc Biopharm  Plc、Elevai Labs, Inc.、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为2890.56%、221.09%、198.74%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Cero Therapeutics Holdings, Inc.，振幅分别为125.68%、114.92%、62.87%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115224350abc4ee7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115224350abc4ee7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2483386887","title":"Atara Biotherapeutics, Inc.盘中异动 早盘急速下跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483386887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483386887?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:50","pubTimestamp":1731599454,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时50分，Atara Biotherapeutics, Inc.股票出现异动，股价快速下跌5.33%。截至发稿，该股报13.50美元/股，成交量3.8465万股，换手率0.68%，振幅8.42%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、奥麦罗制药、Pulmatrix, Inc.涨幅较大，Elevai Labs, Inc.、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为2735.62%、246.85%、40.23%，振幅较大的相关个股有Pulmatrix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、奥麦罗制药，振幅分别为112.92%、86.36%、73.75%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114235054a237fb6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114235054a237fb6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2483667881","title":"Atara Biotherapeutics, Inc.盘中异动 早盘股价大涨5.40%报12.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483667881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483667881?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:31","pubTimestamp":1731508274,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时31分，Atara Biotherapeutics, Inc.股票出现异动，股价快速拉升5.40%。截至发稿，该股报12.30美元/股，成交量5997股，换手率0.11%，振幅0.00%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Kairos Pharma, Ltd.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为323.60%、168.25%、84.06%，振幅较大的相关个股有Entero Therapeutics Inc.、Turnstone Biologics Corp.、Cyclacel Pharmaceuticals, Inc.，振幅分别为8.29%、7.65%、7.63%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223114abbddd46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223114abbddd46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2483647370","title":"Atara Biotherapeutics Inc 报告本季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483647370","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483647370?lang=zh_cn&edition=full","pubTime":"2024-11-13 07:16","pubTimestamp":1731453372,"startTime":"0","endTime":"0","summary":"Atara Biotherapeutics Inc 报告本季度业绩 - 收益摘要Atara Biotherapeutics Inc ATRA.OQ报告本季度调整后每股亏损2.93美元，高于去年同期的每股收益16.50美元。六位分析师对该季度的平均预期是每股亏损 1.93 美元。华尔街预期为每股亏损 4.67 美元至 5 美分。Atara Biotherapeutics Inc公布的本季度每股收益为亏损2.93美元。Atara Biotherapeutics Inc本季度股价上涨了44.8%，今年迄今为止亏损了8.2%。华尔街对 Atara Biotherapeutics Inc 的 12 个月目标价中位数为 10.00 本摘要由 LSEG 11 月 12 日 11:15 p.m. UTC 调制解调器器生成。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nL4T3MJ2HQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2483103990","title":"Atara Biotherapeutics, Inc.盘中异动 股价大跌5.01%报11.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483103990","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483103990?lang=zh_cn&edition=full","pubTime":"2024-11-13 01:22","pubTimestamp":1731432139,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日01时22分，Atara Biotherapeutics, Inc.股票出现异动，股价大幅下跌5.01%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Genprex, Inc.涨幅较大，Genprex, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为446.43%、401.86%、205.07%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Geovax Labs Inc C/Wts 29/09/2025、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为209.30%、105.45%、86.87%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113012219971a6166&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113012219971a6166&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2482388237","title":"Atara Biotherapeutics, Inc.盘中异动 大幅上涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482388237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482388237?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:37","pubTimestamp":1731335853,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时37分，Atara Biotherapeutics, Inc.股票出现波动，股价快速上涨5.13%。截至发稿，该股报11.89美元/股，成交量4995股，换手率0.09%，振幅2.41%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Cero Therapeutics Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Revelation Biosciences, Inc.涨幅较大，Revelation Biosciences, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为417.90%、154.55%、79.12%，振幅较大的相关个股有Windtree Therapeutics, Inc.、Proqr Therapeutics N.V.、Milestone Pharmaceuticals Inc.，振幅分别为109.04%、107.16%、105.56%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223733971a5b39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223733971a5b39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2482468413","title":"Atara Biotherapeutics Inc 预计每股亏损1.93美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482468413","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482468413?lang=zh_cn&edition=full","pubTime":"2024-11-09 07:14","pubTimestamp":1731107680,"startTime":"0","endTime":"0","summary":"Atara Biotherapeutics Inc 预计每股亏损1.93美元 - 财报前瞻Atara Biotherapeutics Inc ATRA.OQ ATRA.O将于11月12日公布截至2024年9月30日的财报，预计季度收入将有所增长。根据LSEG的数据，5位分析师的平均预期显示，这家总部位于加利福尼亚州千橡市的公司的营收预计将从去年同期的214万美元增长1544.9%，达到3516.8万美元。LSEG 的分析师平均预计 Atara Biotherapeutics Inc 每股亏损 1.93 美元。华尔街对 Atara Biotherapeutics Inc 的 12 个月目标价中位数为 14.00 美元，高于其上次收盘价 10.10 美元。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4T3MF2Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATRA"],"gpt_icon":0},{"id":"2481488128","title":"Atara Biotherapeutics, Inc.盘中异动 早盘急速拉升5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481488128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481488128?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:21","pubTimestamp":1731079295,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时21分，Atara Biotherapeutics, Inc.股票出现波动，股价急速上涨5.35%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029、Fortrea Holdings Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为564.26%、48.43%、42.40%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为86.00%、40.00%、31.72%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108232136a224e0ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108232136a224e0ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2481860439","title":"Atara Biotherapeutics, Inc.盘中异动 早盘股价大跌5.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481860439","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481860439?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:57","pubTimestamp":1730905038,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时57分，Atara Biotherapeutics, Inc.股票出现波动，股价快速跳水5.89%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.89%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1319.23%、171.41%、73.01%，振幅较大的相关个股有Sonnet Biotherapeutics Holdings, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为59.38%、43.75%、32.45%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106225718aba6c06c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106225718aba6c06c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2481868535","title":"Atara Biotherapeutics, Inc.盘中异动 股价大跌5.16%报11.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481868535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481868535?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:45","pubTimestamp":1730817909,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时45分，Atara Biotherapeutics, Inc.股票出现波动，股价快速下跌5.16%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Bionomics Ltd Ads Each Rep 180 Ord Shs、Zyversa Therapeutics, Inc.、Nutriband Inc C/Wts 涨幅较大，Zyversa Therapeutics, Inc.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Elevai Labs, Inc.较为活跃，换手率分别为3820.07%、1251.75%、467.97%，振幅较大的相关个股有Bionomics Ltd Ads Each Rep 180 Ord Shs、Zyversa Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为67.30%、42.31%、18.90%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105224509aba24300&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105224509aba24300&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATRA"],"gpt_icon":0},{"id":"2480808587","title":"Atara Biotherapeutics, Inc.盘中异动 股价大涨6.34%报10.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480808587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480808587?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:03","pubTimestamp":1730732632,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时03分，Atara Biotherapeutics, Inc.股票出现波动，股价大幅拉升6.34%。截至发稿，该股报10.33美元/股，成交量3.3943万股，换手率0.60%，振幅4.94%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Neurogene Inc.、Disc Medicine, Inc.、In8Bio, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为258.84%、221.94%、57.31%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、In8Bio, Inc.、Briacell Therapeutics Corp C/Wts 24/02/2025，振幅分别为31.90%、31.42%、29.83%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110423035298e404d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110423035298e404d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATRA","BK4139"],"gpt_icon":0},{"id":"2480288199","title":"Atara Biotherapeutics Inc   预计每股亏损1.93美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480288199","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480288199?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:03","pubTimestamp":1730469798,"startTime":"0","endTime":"0","summary":"   * Atara Biotherapeutics Inc    预计将在11月4日公布截至2024年9月30日的业绩(估计)，季度收入将有所增长。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于加利福尼亚州千橡市的公司的营收预计将从去年同期的214万美元增长1544.9%，达到3516.8万美元。* LSEG 的分析师平均预计 Atara Biotherapeutics Inc 每股亏损 1.93 美元。* 华尔街对 Atara Biotherapeutics Inc 的 12 个月目标价中位数为 14.00 美元，高于其上一次收盘价 8.91 美元。11月1日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Atara Biotherapeutics Inc   预计每股亏损1.93美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATRA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atarabio.com","stockEarnings":[{"period":"1week","weight":0.0697},{"period":"1month","weight":0.4093},{"period":"3month","weight":0.7719},{"period":"6month","weight":-0.1343},{"period":"1year","weight":-0.2561},{"period":"ytd","weight":-0.0546}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Atara Biotherapeutics, Inc.于2012年8月22日在特拉华州成立。公司是一个临床阶段的生物制药公司，致力于开发对肌肉萎缩情况和肿瘤学严重的未满足的医疗需求的新疗法。公司的候选产品是针对肌肉生长抑制素和激活素生物制剂，是TGF-β蛋白超家族的成员，它在肌肉和其他许多身体组织的生长和维持中发挥作用。公司的主导候选产品，PINTA745，是在终末期肾病患者的第2阶段临床试验PEW。该公司第二候选产品为STM434，以及该公司预计将在2014年下半年进入STM434的第1阶段临床研究卵巢癌等实体瘤。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.120552},{"month":2,"riseRate":0.3,"avgChangeRate":-0.046815},{"month":3,"riseRate":0.5,"avgChangeRate":0.062248},{"month":4,"riseRate":0.1,"avgChangeRate":-0.077789},{"month":5,"riseRate":0.4,"avgChangeRate":-0.075569},{"month":6,"riseRate":0.7,"avgChangeRate":0.075872},{"month":7,"riseRate":0.6,"avgChangeRate":-0.046068},{"month":8,"riseRate":0.5,"avgChangeRate":-0.037443},{"month":9,"riseRate":0.7,"avgChangeRate":0.015932},{"month":10,"riseRate":0.2,"avgChangeRate":-0.106288},{"month":11,"riseRate":0.818182,"avgChangeRate":0.251594},{"month":12,"riseRate":0.2,"avgChangeRate":-0.11122}],"exchange":"NASDAQ","name":"Atara Biotherapeutics","nameEN":"Atara Biotherapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Atara Biotherapeutics(ATRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Atara Biotherapeutics(ATRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Atara Biotherapeutics,ATRA,Atara Biotherapeutics股票,Atara Biotherapeutics股票老虎,Atara Biotherapeutics股票老虎国际,Atara Biotherapeutics行情,Atara Biotherapeutics股票行情,Atara Biotherapeutics股价,Atara Biotherapeutics股市,Atara Biotherapeutics股票价格,Atara Biotherapeutics股票交易,Atara Biotherapeutics股票购买,Atara Biotherapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Atara Biotherapeutics(ATRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Atara Biotherapeutics(ATRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}